{"id":"https://openalex.org/W4414785071","doi":"https://doi.org/10.3389/fcvm.2025.1586731","title":"Clinical characteristics and influencing factors of cardiovascular comorbidities in psoriasis","display_name":"Clinical characteristics and influencing factors of cardiovascular comorbidities in psoriasis","publication_year":2025,"publication_date":"2025-10-03","ids":{"openalex":"https://openalex.org/W4414785071","doi":"https://doi.org/10.3389/fcvm.2025.1586731","pmid":"https://pubmed.ncbi.nlm.nih.gov/41112228"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2025.1586731","doi":"https://doi.org/10.3389/fcvm.2025.1586731","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2025.1586731","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1586731/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1586731/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065631540","display_name":"Xinrui Dai","orcid":"https://orcid.org/0009-0007-4960-0292","observed_orcids":["https://orcid.org/0009-0007-4960-0292"]},"institutions":[{"id":"https://openalex.org/I4210110899","display_name":"Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital","ror":"https://ror.org/0160cqn49","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210110899"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xinrui Dai","raw_affiliation_strings":["Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210110899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035448776","display_name":"Xiaoyue Qin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoyue Qin","raw_affiliation_strings":["Department of General Practice, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Practice, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100781942","display_name":"Zongyang Li","orcid":"https://orcid.org/0000-0003-4479-0676","observed_orcids":["https://orcid.org/0000-0003-4479-0676"]},"institutions":[{"id":"https://openalex.org/I17747738","display_name":"Beijing University of Chinese Medicine","ror":"https://ror.org/05damtm70","country_code":"CN","type":"education","lineage":["https://openalex.org/I17747738"]},{"id":"https://openalex.org/I2801051648","display_name":"China-Japan Friendship Hospital","ror":"https://ror.org/037cjxp13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801051648"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zongyang Li","raw_affiliation_strings":["Beijing University of Chinese Medicine, Beijing, China","Department of Dermatology, China-Japan Friendship Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing University of Chinese Medicine, Beijing, China","institution_ids":["https://openalex.org/I17747738"]},{"raw_affiliation_string":"Department of Dermatology, China-Japan Friendship Hospital, Beijing, China","institution_ids":["https://openalex.org/I2801051648"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065631540"],"corresponding_institution_ids":["https://openalex.org/I4210110899"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.6101,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.67151684,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"1586731","last_page":"1586731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cardiovascular-comorbidity","display_name":"cardiovascular comorbidity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8140000104904175},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9639999866485596},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":1.0},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9850000143051147},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/psoriasis-severity","display_name":"psoriasis severity","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pasi-score","display_name":"PASI score","score":0.8320000171661377},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.8840000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9204000234603882},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8023999929428101},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.48249998688697815},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4307999908924103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4163999855518341},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4104999899864197},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.39010000228881836},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.3531000018119812},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3325999975204468},{"id":"https://openalex.org/C3018284874","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Cardiovascular health","level":3,"score":0.31700000166893005},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31029999256134033},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.3000999987125397},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.274399995803833},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.25929999351501465}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fcvm.2025.1586731","doi":"https://doi.org/10.3389/fcvm.2025.1586731","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2025.1586731","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1586731/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},{"id":"pmid:41112228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41112228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cardiovascular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:11341177","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12533279","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:8040c0675bb54d27b9fd0db854b20cf9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8040c0675bb54d27b9fd0db854b20cf9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cardiovascular Medicine, Vol 12 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2025.1586731","doi":"https://doi.org/10.3389/fcvm.2025.1586731","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2025.1586731","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1586731/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414785071.pdf","grobid_xml":"https://content.openalex.org/works/W4414785071.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1994108698","https://openalex.org/W2022665587","https://openalex.org/W2028621745","https://openalex.org/W2409904785","https://openalex.org/W2573502983","https://openalex.org/W2589980631","https://openalex.org/W2594006688","https://openalex.org/W2804753859","https://openalex.org/W2899887833","https://openalex.org/W2901559347","https://openalex.org/W2963660305","https://openalex.org/W2981880933","https://openalex.org/W2988994560","https://openalex.org/W2990548943","https://openalex.org/W3008728180","https://openalex.org/W3045515316","https://openalex.org/W3083558889","https://openalex.org/W4206408806","https://openalex.org/W4296959212","https://openalex.org/W4297676455","https://openalex.org/W4308019804","https://openalex.org/W4319019513","https://openalex.org/W4361212055","https://openalex.org/W4385953025","https://openalex.org/W4386438912","https://openalex.org/W4388023834","https://openalex.org/W4392546428","https://openalex.org/W4394999960","https://openalex.org/W4395053963","https://openalex.org/W4405102600","https://openalex.org/W4410526666"],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Psoriasis":[1,193],"is":[2],"a":[3,51,180,199],"chronic":[4],"inflammatory":[5,82,203],"skin":[6],"disorder":[7],"with":[8,59,72,173,179,195,213],"systemic":[9,27],"implications,":[10],"including":[11],"an":[12],"elevated":[13,142],"risk":[14,222],"of":[15,40,55,102,125,164,210,216],"cardiovascular":[16,32,69,196,226,239],"disease":[17,152],"(CVD).":[18],"The":[19],"interaction":[20],"between":[21],"psoriasis":[22,43,75,171,218],"severity,":[23],"metabolic":[24],"abnormalities,":[25],"and":[26,38,81,106,134,159,202,220],"inflammation":[28],"may":[29],"contribute":[30],"to":[31,68,98,113,224],"comorbidities.":[33],"However,":[34],"the":[35,176,208],"clinical":[36,201],"characteristics":[37],"predictors":[39,101,163],"CVD":[41,73],"in":[42,241],"patients":[44,58,194],"remain":[45],"incompletely":[46],"understood.":[47],"Methods:":[48],"We":[49],"conducted":[50],"retrospective":[52],"cohort":[53],"study":[54],"320":[56],"adult":[57],"psoriasis.":[60,242],"Participants":[61],"were":[62,84,111],"categorized":[63],"into":[64],"two":[65],"groups":[66],"according":[67],"status":[70],"(psoriasis":[71],"vs.":[74,128,132,137],"without":[76],"CVD).":[77],"Demographic,":[78],"clinical,":[79],"metabolic,":[80],"parameters":[83],"compared.":[85],"Variable":[86],"selection":[87],"was":[88],"performed":[89],"using":[90],"LASSO":[91],"regression,":[92],"followed":[93],"by":[94],"multivariable":[95],"logistic":[96],"regression":[97,147],"identify":[99],"independent":[100,162],"CVD.":[103,165],"Kaplan-Meier":[104,166],"curves":[105],"Cox":[107],"proportional":[108],"hazards":[109],"models":[110],"applied":[112],"evaluate":[114,232],"survival":[115,184],"outcomes.":[116],"Results:":[117],"<":[118],"0.001).":[119],"They":[120],"also":[121],"exhibited":[122],"higher":[123,154],"prevalence":[124],"hypertension":[126,174],"(68.2%":[127],"20.7%),":[129],"diabetes":[130],"(25.0%":[131],"10.3%),":[133],"dyslipidemia":[135],"(50.0%":[136],"22.4%),":[138],"as":[139,141,161],"well":[140],"C-reactive":[143],"protein":[144],"levels.":[145],"Multivariable":[146],"identified":[148],"older":[149],"age,":[150],"longer":[151],"duration,":[153],"PASI":[155],"scores,":[156],"hypertension,":[157],"diabetes,":[158],"CRP":[160],"analysis":[167],"showed":[168],"that":[169],"severe":[170],"combined":[172],"conferred":[175],"greatest":[177],"risk,":[178],"significantly":[181],"lower":[182],"CVD-free":[183],"probability":[185],"(adjusted":[186],"HR:":[187],"3.56,":[188],"95%":[189],"CI:":[190],"2.01-6.31).":[191],"Discussion:":[192],"comorbidities":[197],"demonstrate":[198],"distinct":[200],"profile.":[204],"Our":[205],"findings":[206],"underscore":[207],"importance":[209],"integrated":[211],"management,":[212],"aggressive":[214],"control":[215],"both":[217],"severity":[219],"traditional":[221],"factors":[223],"mitigate":[225],"burden.":[227],"Future":[228],"prospective":[229],"studies":[230],"should":[231],"whether":[233],"targeted":[234],"anti-inflammatory":[235],"therapies":[236],"can":[237],"reduce":[238],"outcomes":[240]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}